Protagonist Therapeutics, Inc - Common Stock (PTGX)

CUSIP: 74366E102

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / Common Stock
Shares outstanding
62,457,444
Total 13F shares
11,933,401
Share change
+125,477
Total reported value
$102,508,360
Price per share
$8.59
Number of holders
67
Value change
-$12,039,057
Number of buys
47
Number of sells
28

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
4.9%
3,071,949
$63,897,000 31 Dec 2017
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
3.3%
2,056,076
$42,766,000 31 Dec 2017
13F
Pharmstandard International S.A.
13F
Company
1.6%
982,270
$20,431,000 31 Dec 2017
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
1.4%
900,000
$18,720,000 31 Dec 2017
13F
BlackRock Finance, Inc.
13F
Company
0.79%
494,528
$10,286,000 31 Dec 2017
13F
VANGUARD GROUP INC
13F
Company
0.77%
482,545
$10,037,000 31 Dec 2017
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.67%
416,364
$8,660,000 31 Dec 2017
13F
Cormorant Asset Management, LP
13F
Company
0.64%
400,000
$8,320,000 31 Dec 2017
13F
BVF INC/IL
13F
Company
0.47%
294,117
$6,118,000 31 Dec 2017
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.44%
275,000
$5,720,000 31 Dec 2017
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.36%
225,000
$4,680,000 31 Dec 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.33%
204,759
$4,258,000 31 Dec 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.31%
192,730
$4,009,000 31 Dec 2017
13F
SENZAR ASSET MANAGEMENT, LLC
13F
Company
0.29%
180,000
$3,744,000 31 Dec 2017
13F
AWM Investment Company, Inc.
13F
Company
0.28%
177,212
$3,686,000 31 Dec 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.22%
139,977
$2,911,000 31 Dec 2017
13F
STATE STREET CORP
13F
Company
0.22%
136,844
$2,847,000 31 Dec 2017
13F
NORTHERN TRUST CORP
13F
Company
0.2%
127,288
$2,647,000 31 Dec 2017
13F
Point72 Asset Management, L.P.
13F
Company
0.19%
120,000
$2,496,000 31 Dec 2017
13F
JENNISON ASSOCIATES LLC
13F
Company
0.16%
100,000
$2,080,000 31 Dec 2017
13F
Tekla Capital Management LLC
13F
Company
0.13%
82,822
$1,723,000 31 Dec 2017
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.09%
57,776
$1,202,000 31 Dec 2017
13F
Alyeska Investment Group, L.P.
13F
Company
0.08%
50,000
$1,040,000 31 Dec 2017
13F
Polar Capital LLP
13F
Company
0.08%
50,000
$1,040,000 31 Dec 2017
13F
FRANKLIN STREET ADVISORS INC /NC
13F
Company
0.07%
46,700
$971,000 31 Dec 2017
13F
Bank of New York Mellon Corp
13F
Company
0.07%
44,473
$925,000 31 Dec 2017
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.06%
39,000
$811,000 31 Dec 2017
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.05%
33,302
$680,000 31 Dec 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.05%
32,534
$677,000 31 Dec 2017
13F
D. E. Shaw & Co., Inc.
13F
Company
0.05%
31,251
$650,000 31 Dec 2017
13F
PDT Partners, LLC
13F
Company
0.05%
30,266
$630,000 31 Dec 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.05%
29,563
$615,000 31 Dec 2017
13F
MORGAN STANLEY
13F
Company
0.04%
27,584
$574,000 31 Dec 2017
13F
Numeric Investors LLC
13F
Company
0.04%
26,819
$558,000 31 Dec 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.04%
26,084
$541,000 31 Dec 2017
13F
ALPS ADVISORS INC
13F
Company
0.04%
22,694
$472,000 31 Dec 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.03%
21,593
$449,000 31 Dec 2017
13F
Spark Investment Management LLC
13F
Company
0.03%
21,500
$447,000 31 Dec 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.03%
19,300
$402,000 31 Dec 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.03%
17,965
$374,000 31 Dec 2017
13F
FEDERATED HERMES, INC.
13F
Company
0.03%
17,425
$362,000 31 Dec 2017
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.03%
17,400
$362,000 31 Dec 2017
13F
Trexquant Investment LP
13F
Company
0.03%
17,106
$356,000 31 Dec 2017
13F
Dynamic Technology Lab Private Ltd
13F
Company
0.02%
11,363
$236,000 31 Dec 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
10,200
$212,000 31 Dec 2017
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.02%
9,821
$204,000 31 Dec 2017
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.02%
9,459
$197,000 31 Dec 2017
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
9,423
$196,000 31 Dec 2017
13F
BARCLAYS PLC
13F
Company
0.01%
8,216
$171,000 31 Dec 2017
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
7,677
$160,000 31 Dec 2017
13F

Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q1 2018

As of 31 Mar 2018, Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,933,401 shares. The largest 10 holders included FMR LLC, EcoR1 Capital, LLC, FARALLON CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pharmstandard International S.A., BlackRock Inc., VANGUARD GROUP INC, BVF INC/IL, Cormorant Asset Management, LP, and MILLENNIUM MANAGEMENT LLC. This page lists 67 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders
64
Q1 2018 holders
67
Holder diff
3
Investor Q4 2017 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2017 Value $ Q1 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.